Prognostic relevance of programmed death-ligand 1 expression and microsatellite status in small bowel adenocarcinoma

Background: Small bowel adenocarcinoma (SBA) is a dreadful disease. Patient prognosis is limited due to late presentation and ineffective chemotherapy. PD-1/PD-L1 checkpoint immunotherapy is regarded as a promising approach in several cancer entities. The association of PD-1/PD-L1 expression and its...

Full description

Saved in:
Bibliographic Details
Main Authors: Klose, Johannes (Author) , Lasitschka, Felix (Author) , Horsch, Cornelia (Author) , Strowitzki, Moritz (Author) , Bruckner, Thomas (Author) , Volz, Claudia (Author) , Schmidt, Thomas (Author) , Schneider, Martin (Author)
Format: Article (Journal)
Language:English
Published: 19 Mar 2020
In: Scandinavian journal of gastroenterology
Year: 2020, Volume: 55, Issue: 3, Pages: 321-329
ISSN:1502-7708
DOI:10.1080/00365521.2020.1734073
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/00365521.2020.1734073
Get full text
Author Notes:Johannes Klose, Felix Lasitschka, Cornelia Horsch, Moritz J. Strowitzki, Thomas Bruckner, Claudia Volz, Thomas Schmidt, Martin Schneider
Description
Summary:Background: Small bowel adenocarcinoma (SBA) is a dreadful disease. Patient prognosis is limited due to late presentation and ineffective chemotherapy. PD-1/PD-L1 checkpoint immunotherapy is regarded as a promising approach in several cancer entities. The association of PD-1/PD-L1 expression and its impact on patient prognosis with SBA is unclear. Material and methods: Seventy-five consecutive patients who underwent surgery for SBA were retrospectively analyzed and stained for PD-L1 expression in the tumour or the stroma. Analysis of mismatch repair genes was performed to determine microsatellite status. Kaplan-Meier estimate was used to analyze patient survival. Univariate and multivariable Cox regression-analyses were used to assess the impact of PD-L1 expression and microsatellite status on patient survival.Results: PD-L1 was weakly upregulated within the tumour or the stroma and associated with prolonged survival (p = .0071 and p = .0472, respectively). Fifty-one tumours (68%) revealed microsatellite stability (MSS) and 24 tumours (32%) were microsatellite instable (MSI) without correlating with patient survival (p = .611). Neither PD-L1 expression in the tumour nor in the stroma was identified as an independent risk factor influencing survival (p = .572 and p = .3055).Conclusion: Although PD-L1 expression is associated with prolonged survival, it was not identified as an independent prognostic marker. Microsatellite status did not influence long-term survival.
Item Description:Gesehen am 17.04.2020
Physical Description:Online Resource
ISSN:1502-7708
DOI:10.1080/00365521.2020.1734073